30050BAH4
Evolent Health, Inc.
Could not find a ticker for this position, may be a filing error
A healthcare services company that helps health plans, providers, and hospitals manage complex, high-cost conditions like cancer, heart disease, and musculoskeletal care. It uses its Identifi technology platform and clinical programs to help organizations move from simply billing per visit to "value-based care" that rewards better outcomes. Evolent was founded in 2011 as a joint venture between UPMC and The Advisory Board Company, based in Arlington, Virginia. Its name blends "evolution" and "benevolent," chosen to signal a kinder, transforming approach to healthcare.
CONVERTIBLEUnderlying: EVHCUSIP: 30050BAH4HealthcareUS1 derivative reporter
3.5% Convertible Senior Notes due 2029
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
